google_counter
background_img

Treatment of acute myeloid leukemia (AML) with CAR T-cell therapy (program ID: 666007)

University Hospital RWTH Aachen

location_on Aachen, Germany
8.7/10 from 41 Votes
Specialized hospital
Edgar Jost

Head Physician
PD Dr. med.

Edgar Jost

Specialized in: oncology, hematology

Department of Oncology and Hematology

Program includes:

  • Initial presentation in the clinic
  • Clinical history taking
  • Physical examination
  • Review of medical records
  • Laboratory tests:
    • Complete blood count
    • General urine analysis
    • Biochemical blood test (kidney and liver function tests)
    • Indicators of inflammation (CRP, ESR)
    • Indicators of blood coagulation
    • Immunohistochemical and genetic analysis of tumor cells (if indicated)
  • Leukapheresis, processing of T-cells and cultivation of CAR T-cells
  • Adjuvant chemotherapy
  • Infusion of modified CAR T-cells to a patient
  • Control examinations
  • Cost of essential medicines and materials
  • Nursing services
  • Full hospital accommodation
  • Explanation of future recommendations

Indications

  • Acute myeloid leukemia (AML) that is resistant to the conventional therapy

How program is carried out

Days 1-2. Initial presentation at the clinic. The doctor collects the patient's medical history, looks at his medical records and previous examinations. Special attention is paid to previous cancer treatments and their results, since CAR T-cell therapy is indicated only if the conventional treatment protocols are ineffective. Based on the results of the consultation, the doctor administers the examination, which includes a complete blood count with white blood cell count, assessment of liver and kidney function, immunohistochemical and genetic analysis of tumor cells (if indicated) and other studies.

Day 3. Collecting patient’s blood. During the leukapheresis procedure, doctors harvest at least 100 million T-cells, which will subsequently undergo gene modification. If there are certain clinical reasons, and the patient needs to postpone the subsequent stages of CAR T-cell therapy, the harvested T-cells undergo the procedure of cryoconservation. If the patient is able to continue treatment immediately, then the harvested T-cells are transferred to the laboratory.

Days 4-12. Processing and gene modification of the T-cells pool lasts 7-10 days. During this time, the patient is receiving immunosuppressive chemotherapy drugs. The chemotherapy is aimed at suppressing the patient's own immune system, which will allow CAR T-cells to fight the tumor more effectively.

Day 13. Manufactured CAR T-cells are tested for the microbiological safety and functional activity. After the successful testing completion, the solution with CAR T-cells is administered to the patient intravenously.

Day 14 and other days. Control examination and further medical supervision in the hospital are carried out. If there are no side effects of CAR T-cell therapy, a stable tendency towards normalization of blood count is observed and the patient has stable general health condition, the patient is discharged from the hospital. Before the discharge, the patient receives the detailed recommendations for further follow-up during the disease remission.

Required documents

  • Complete blood count with white blood cell count
  • Biochemical blood test (renal and liver function tests), if available
  • Bone marrow biopsy results
  • CT scan, if available
Service
Price:
Type of program :
Expected duration of the program:

You may also book

Price:

About the department

The Department of Oncology and Hematology at the University Hospital RWTH Aachen offers accurate diagnostics and effective treatment of benign and malignant blood diseases, as well as solid tumors. The department's specialists are proud of the excellent results in the field of bone marrow transplantation, which is among the department’s priority focuses. The department has 61 beds. Medical care is carried out both on an outpatient and inpatient basis. The department is headed by PD Dr. med. Edgar Jost.

The department specializes in the diagnostics and treatment of leukemias and lymphomas, as well as aplastic syndromes, mast cell diseases and myeloproliferative neoplasms. The priorities of inpatient medical care are the treatment of acute leukemias and high-dose chemotherapy. In the field of solid tumor treatment, the department is known for systemic therapy of lung cancer, head and neck tumors, sarcomas, etc. In addition, the standard services include supportive treatment and systematic psycho-oncological consultations.

The department cooperates closely with the Euregional Comprehensive Cancer Center Aachen. Therefore, the department has an access to the very latest diagnostic and treatment methods, as well as the opportunity to engage all the necessary specialists to the treatment process. The therapy of cancers requires particularly professional and comprehensive approach, and therefore the treatment strategy for each patient is developed individually with the participation of oncologists, radiologists, radiation therapists, specialized doctors (for example, otolaryngologists, orthopedists), etc. The psycho-oncological care also plays an important role in the treatment process, since when the patients hear the diagnosis of cancer, they often lose heart and cannot cope with an emotional stress on their own. If desired, the treatment within the clinical trials is possible.

The department provides the diagnostics and treatment of the following pathologies:

  • Myelodysplastic syndrome
  • Acute myeloid leukemias
  • Chronic myeloid leukemias
  • Aplastic syndromes (for example, aplastic anemia, paroxysmal nocturnal hemoglobinuria)
  • Hereditary and acquired anemias
  • Blood clotting disorders
  • Multiple myeloma
  • Myeloproliferative neoplasms (for example, essential thrombocythemia, true polycythemia, primary myelofibrosis)
  • Brain tumors
  • Lymphomas of the central nervous system 
  • Head and neck tumors
  • Lung cancer
  • Lymphomas
  • Melanomas (choroidal, metastatic melanomas)
  • Other diseases

Photo of the doctor: (c) Uniklinik RWTH Aachen 


About hospital

Accommodation in hospital

There are 26 acute myeloid leukemia treatment hospitals on Booking Health website

Show all clinics

Certificates

Need Help?

Thank you!

We received your treatment application in the best Europe clinics. Our manager will contact you within the next 24 hours.